Julie Gralow News Today : Breaking News, Live Updates & Top Stories | Vimarsana

He Is Not a Comic Book Super-Villain : What We Heard This Week

Quotable quotes heard by <em>MedPage Today</em>'s reporters

United statesColumbia universityNew yorkTufts medical centerJulie gralowMunira gunjaJason liebowitzAnthony fauciJohn hertigMarilyn serafiniHealth project for the bipartisan policy centerButler university in indianapolisCommonwealth fund international program in healthAmerican society of clinical oncologySupreme court dobbsEndocrine society

Neoadjuvant Strategy Establishes Standard of Care for Resectable Stage III Melanoma

A third as many clinical events versus adjuvant therapy, 6 weeks of treatment for many patients

Noord hollandUnited statesCharles bankheadMichael loweJulie gralowNetherlands cancer instituteAmerican society of clinical oncologyEmory university in atlantaAmerican societyClinical oncologyEmory universityMedpage today

REACH PC Trial: Early Palliative Care Via Telehealth Has Equivalent Efficacy to On-Site Visits for Patients With Advanced NSCLC

REACH PC Trial: Early Palliative Care Via Telehealth Has Equivalent Efficacy to On-Site Visits for Patients With Advanced NSCLC
pharmacytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmacytimes.com Daily Mail and Mail on Sunday newspapers.

United statesCharu aggarwalLeslyem heislerJeff bergenJulie gralowJoseph greerPenn centerAmerican society of clinical oncologyPsychiatric oncology behavioral sciencesUniversity of pennsylvaniaResearch implicationsPatient healthCancer outcomes research education programHospital cancer centerClinical oncologyCancer outcomes research

Antibody-Drug Conjugate Picks Up Another Win in HR+/HER2-low Breast Cancer

Trastuzumab deruxtecan extended its superiority versus chemotherapy into HER2-ultralow

United statesJulie gralowGiuseppe curiglianoCharles bankheadErica mayerAmerican society of clinical oncologyEuropean institute of oncologyUniversity of milanEuropean instituteAmerican societyClinical oncologyDana farber cancerMedpage today

Kinder, Gentler Regimen for Classical Hodgkin Prevails in Randomized Trial

Better efficacy with brentuximab vedotin versus standard chemo, substantially less toxicity

United statesDana farber cancer institutePeter borchmannCharles bankheadJulie gralowOreofeo odejideUniversity hospital of cologneGerman hodgkin study groupAmerican society of clinical oncologyUniversity hospitalAmerican societyClinical oncologyMedpage today